Hinge Health, Inc.
$54.74-0.40%($-0.22)
TickerSpark Score
58/100
65
Valuation
40
Profitability
55
Growth
52
Health
80
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HNGE research report →
52-Week Range77% of range
Low $30.08
Current $54.74
High $62.18
Companywww.hingehealth.com
Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation.
- CEO
- Daniel A. Perez
- IPO
- 2025
- Employees
- 1,514
- HQ
- San Francisco, CA, US
Price Chart
+45.74% · this period
Valuation
- Market Cap
- $4.24B
- P/E
- -8.43
- P/S
- 6.55
- P/B
- 13.81
- EV/EBITDA
- -7.81
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 80.80%
- Op Margin
- -81.60%
- Net Margin
- -78.95%
- ROE
- -138.70%
- ROIC
- -165.59%
Growth & Income
- Revenue
- $587.86M · 50.58%
- Net Income
- $-528,261,000 · -4326.89%
- EPS
- $-5.36 · -3473.33%
- Op Income
- $-546,371,000
- FCF YoY
- 277.49%
Performance & Tape
- 52W High
- $62.18
- 52W Low
- $30.08
- 50D MA
- $44.69
- 200D MA
- $47.38
- Beta
- 1.65
- Avg Volume
- 1.19M
Get TickerSpark's AI analysis on HNGE
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 29, 26 | Pursley James | other | 65,000 |
| Apr 29, 26 | Budge James | other | 65,000 |
| May 11, 26 | Budge James | sell | 4,706 |
| May 11, 26 | Budge James | sell | 1,200 |
| May 8, 26 | Robinson Elliott | sell | 0 |
| May 6, 26 | Mecklenburg Gabriel M.I. | other | 50,000 |
| May 6, 26 | Mecklenburg Gabriel M.I. | other | 50,000 |
| May 6, 26 | Mecklenburg Gabriel M.I. | sell | 50,000 |
| May 6, 26 | Perez Daniel Antonio | other | 104,544 |
| May 7, 26 | Perez Daniel Antonio | other | 45,426 |
Our HNGE Coverage
We haven't published any research on HNGE yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HNGE Report →Similar Companies
WGS+6.17%
GeneDx Holdings Corp.
$44.73
CRNX+3.81%
Crinetics Pharmaceuticals, Inc.
$36.27
IMVT+35.26%
Immunovant, Inc.
$35.56
PRAX+4.68%
Praxis Precision Medicines, Inc.
$335.61
VKTX+3.66%
Viking Therapeutics, Inc.
$29.44
DYN+10.30%
Dyne Therapeutics, Inc.
$17.56
OSCR-4.49%
Oscar Health, Inc.
$23.42
AKRO+0.00%
Akero Therapeutics, Inc.
$54.65